Multiply Labs

News

Global chipmaker giant NVIDIA kicked off JPM Week with several partnership announcements, including a billion dollar partnership with Eli Lilly.

News

Hengrui's oral TPO agonist, hetrombopag, is the first in the class to be approved for thrombocytopenia caused by chemotherapy for solid tumours.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.